Indications | Dosage form | Development stage | Launch time |
---|---|---|---|
CNS | OD!FS® | ||
Antiviral | OD!FS® | 2Q 2022 | |
Hypertension | Tab. | ||
Hyperlipidemia | Tab. | ||
Asthma | OD!FS® | 4Q 2023 | |
Orphan drug | OD!FS® | 4Q 2023 | |
Health functional food | OD!FS® | 4Q 2022 | |
Food | OD!FS® | 4Q 2022 |